DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)

CUSIP: 256135203

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / American depositary shares, each representing one equity share
Shares outstanding
834,731,296
Total 13F shares
118,585,675
Share change
+87,867,460
Total reported value
$1,871,315,562
Put/Call ratio
32%
Price per share
$15.79
Number of holders
246
Value change
+$1,379,421,949
Number of buys
227
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 256135203?
CUSIP 256135203 identifies RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2024

As of 31 Dec 2024, DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by 246 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 118,585,675 shares. The largest 10 holders included Robeco Institutional Asset Management B.V., MORGAN STANLEY, Royal Bank of Canada, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, Aikya Investment Management Ltd, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, and BNP PARIBAS FINANCIAL MARKETS. This page lists 246 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.